Page 36 - Read Online

Allen et al. Hepatoma Res 2021;7:73 https://dx.doi.org/10.20517/2394-5079.2021.98 Page 15 of 15

66. Siebenhüner AR, Seifert H, Bachmann H, et al. Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: a
prospective single center phase II study. BMC Cancer 2018;18:72. DOI PubMed PMC
67. Nakachi K, Konishi M, Ikeda M, et al. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract
cancer. Int J Clin Oncol 2018;23:894-9. DOI PubMed
68. Kobayashi S, Nagano H, Tomokuni A, et al; Kansai Hepato-Biliary Oncology (KHBO) Group. A prospective, randomized phase II
study of adjuvant gemcitabine versus S-1 after major hepatectomy for biliary tract cancer (KHBO 1208): kansai hepato-biliary
oncology group. Ann Surg 2019;270:230-7. DOI PubMed
69. Itano O, Takemura Y, Kishida N, et al. A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected
biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01). BMC Cancer 2020;20:688. DOI
PubMed PMC
70. Nakachi K, Konishi M, Ikeda M, et al; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group. A
randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan clinical oncology group
study (JCOG1202, ASCOT). Jpn J Clin Oncol 2018;48:392-5. DOI PubMed
71. Nelson JW, Ghafoori AP, Willett CG, et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat
Oncol Biol Phys 2009;73:148-53. DOI PubMed PMC
72. Jung JH, Lee HJ, Lee HS, et al. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar
cholangiocarcinoma. World J Gastroenterol 2017;23:3301-8. DOI PubMed PMC
73. Kobayashi S, Tomokuni A, Gotoh K, et al. A retrospective analysis of the clinical effects of neoadjuvant combination therapy with
full-dose gemcitabine and radiation therapy in patients with biliary tract cancer. Eur J Surg Oncol 2017;43:763-71. DOI PubMed
74. Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer
patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol 2015;22 Suppl
3:S1093-9. DOI PubMed
75. Le Roy B, Gelli M, Pittau G, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Br J Surg
2018;105:839-47. DOI PubMed
76. Lunsford KE, Javle M, Heyne K, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with
neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol 2018;3:337-48. DOI PubMed